KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Teva Pharmaceutical Industries (TEVA) Minority Interest: 2009-2025

Historic Minority Interest for Teva Pharmaceutical Industries (TEVA) over the last 8 years, with Sep 2025 value amounting to $4.0 million.

  • Teva Pharmaceutical Industries' Minority Interest fell 98.75% to $4.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.0 million, marking a year-over-year decrease of 98.75%. This contributed to the annual value of $340.0 million for FY2024, which is 45.16% down from last year.
  • As of Q3 2025, Teva Pharmaceutical Industries' Minority Interest stood at $4.0 million, which was down 42.86% from $7.0 million recorded in Q2 2025.
  • Teva Pharmaceutical Industries' 5-year Minority Interest high stood at $987.0 million for Q2 2021, and its period low was $4.0 million during Q3 2025.
  • Its 3-year average for Minority Interest is $341.4 million, with a median of $319.0 million in 2024.
  • In the last 5 years, Teva Pharmaceutical Industries' Minority Interest increased by 1.54% in 2021 and then crashed by 98.75% in 2025.
  • Over the past 5 years, Teva Pharmaceutical Industries' Minority Interest (Quarterly) stood at $966.0 million in 2021, then decreased by 17.81% to $794.0 million in 2022, then decreased by 21.91% to $620.0 million in 2023, then plummeted by 45.16% to $340.0 million in 2024, then slumped by 98.75% to $4.0 million in 2025.
  • Its Minority Interest stands at $4.0 million for Q3 2025, versus $7.0 million for Q2 2025 and $7.0 million for Q1 2025.